Alphagreen, a European CBD marketplace, has raised nearly £1.7 million through its equity crowdfunding campaign on Seedrs.
Founded in 2019, Alphagreen Group describes itself as a high-growth technology and pharmaceutical trading business.
“Alphagreen Group works with top Cannabis brands globally to sell high-quality non-psychoactive products (e.g. CBD) via a curated online marketplace in the UK, as well as medical Cannabis via an import and distribution model to pharmacies in Germany.”
Alphagreen now covers more than 150 brands in medical cannabis and alternative healthcare.
“Alphagreen is building a trusted ecosystem for customers with Sleep, Pain, and Anxiety problems to access alternative healthcare as well as looking to distribute medical cannabis from Q3 2021.In addition to providing Europe’s largest range of CBD brands and products, Alphagreen has developed what they believe to be the biggest and most accurate representation of product, pricing and demand data in the UK and European CBD markets via its analytics dashboard.”
Alphagreen has two core offerings:
- Alphagreen.io: Alphagreen receives 30% of the retail price of the product with the brands paying for shipping and fulfilment to the customer. Alphagreen also receives revenue from brands paying for display ads, email marketing and sponsored content.
- NUOPTIMA: NUOPTIMA has a recurring revenue model of up to £10,000 per month depending on the range of services provided. Alphagreen Intelligence, the data product, sells for £10,000 for a 6-month contract per user for the basic package and £15,000 for the advanced package.
Funds from the Seedrs campaign will be used to continue the development of Alphagreen’s products. Alphagreen is now offering 14.47% in equity at a £10 million pre-money valuation through the funding round, which is set to close mid-May.
Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!